Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Recommendation of “Hold” from Brokerages
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has received a consensus rating of “Hold” from the eleven analysts that are presently covering the firm, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. […]
More Stories
Stryker (NYSE:SYK) Given New $409.00 Price Target at Truist Financial
Stryker (NYSE:SYK – Free Report) had its target price upped by Truist Financial from $380.00 to $409.00 in a research...
Huntsman (NYSE:HUN) Given New $19.00 Price Target at Citigroup
Huntsman (NYSE:HUN – Free Report) had its target price cut by Citigroup from $22.00 to $19.00 in a research note...
dotdigital Group Plc (LON:DOTD) Announces Dividend Increase – GBX 1.10 Per Share
dotdigital Group Plc (LON:DOTD – Get Free Report) declared a dividend on Wednesday, December 18th,Upcoming Dividends.Co.Uk reports. Stockholders of record...
First Guaranty Bancshares, Inc. (NASDAQ:FGBI) Announces Quarterly Dividend of $0.01
First Guaranty Bancshares, Inc. (NASDAQ:FGBI – Get Free Report) declared a quarterly dividend on Wednesday, December 18th,Wall Street Journal reports....
Yangarra Resources Ltd. (TSE:YGR) Director Penelope Payne Acquires 11,800 Shares of Stock
Yangarra Resources Ltd. (TSE:YGR – Get Free Report) Director Penelope Payne bought 11,800 shares of the firm’s stock in a...
Sylvamo Co. (NYSE:SLVM) to Issue Quarterly Dividend of $0.45
Sylvamo Co. (NYSE:SLVM – Get Free Report) announced a quarterly dividend on Wednesday, December 18th,Wall Street Journal reports. Stockholders of...